Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
-
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
-
Northern Technologies International Corporation Reports Financial Results for First Quarter Fiscal 2026
-
Pan American Energy Reviews 2025 Work and Outlines 2026 Exploration Strategy
-
AmpliTech Group Appoints Professor Tommaso Melodia To Its Board of Advisors to Support Strategic Growth Across ORAN Architectures and AI-native Wireless Networks
-
Made In Cookware Partners with Light Labs for Third-Party Testing to Advance Cookware Safety and Transparency
-
ORYZON to Participate in Upcoming Events in January
-
StoneX Announces Strategic Partnership with Enhanced Digital Group and Leads Series A Funding Round
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY, MAAY, NUGY, SEMY, QBY, RGYY, HMYY and RT
-
InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation
-
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
-
NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway
-
Texxon Holding Limited Completes Key Safety and Regulatory Milestones for 600,000-Ton Polystyrene Project
-
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
-
LiveOne (NASDAQ: LVO) Achieves Major Milestones, Closes $65M+ in Partnership Revenue
-
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
-
IP Strategy Publishes Monthly Validator & Ecosystem Update
-
Diginex Completes Acquisition of The Remedy Project Amid Growing Global Demand for Human Rights Due Diligence in Supply Chains
-
Vickery Energy Acquires Appalachia Gas Assets from Tribune Resources
-
Pentec Health Acquires Hartley Medical, Advancing Intrathecal Pain and Implanted Pump Management
-
R1 Launches Phare Audit, the AI-Native Solution to Capture Full Reimbursement, Reduce Revenue Leakage and Improve Quality
-
Navigator Medicines Accelerates Anti OX-40L and TNFα Bispecific Antibody Clinical Development Pipeline into Phase 2a and First-in-Human Trials
-
Satellogic Announces Seven-Figure Monitoring Agreement with Strategic Customer
-
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
-
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
-
G Squared and Nasdaq Private Market Announce Strategic Partnership to Power Liquidity for Private Company Employees and Shareholders
-
CareCloud Brings Wellsoft to Urgent Care with Affinity Deal, Targeting a Larger Nationwide Market Opportunity
-
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621
-
SiTime to Present at the Needham Growth Conference on January 13, 2026
-
Meltwater Achieves SOC 2 Type II Certification, Reinforcing Commitment to Data Security and Trust
-
California Resources Corporation and Los Angeles Rams Score in Carbon Management Initiative
-
The Global CEO Initiative on Alzheimer’s Disease Publishes Consensus Recommendations for Clinic-Based Digital Cognitive Assessments
-
RAMSEY SOLUTIONS RELAUNCHES EVERYDOLLAR TO HELP USERS ACHIEVE $20 BILLION IN FINANCIAL TRANSFORMATION PER YEAR BY 2030
-
Getty Realty Corp. Provides 2025 Business Update
-
LPL Financial Welcomes Rand, Williams & Associates, LLC
-
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
-
Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care
-
CytomX Therapeutics Announces Business Update and Company Milestones for 2026
-
Collegium Provides 2026 Financial Guidance and Business Update
-
AirJoule Technologies Begins Net Zero Innovation Hub for Data Centers Program and Advances Commercial Deployment with Google, Microsoft, and Industry Leaders
-
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
-
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Skyharbour Announces Additional Uranium Property Staking Increasing Total Portfolio to Over 662,000 Hectares in the Athabasca Basin, Saskatchewan
-
Abacus Global Management Chairman and CEO Jay Jackson Releases Shareholder Letter
-
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
-
Coralogix Announces U.S. Department of Education Sponsorship for FedRAMP® Authorization
-
Photronics Appoints Jeff Catlin Senior Vice President, Global Sales
-
Blue Star Families Welcomes New Advisory Board Members to Advance Military Family Initiatives
-
St John Ambulance partners with Simpson Associates to build the foundations for data transformation
-
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
